Zacks.com on MSN7h
CHMP Endorses Merck's Kidney Cancer Drug for Two IndicationsThe CHMP's opinion is based on positive results from two late-stage studies on MRK's Welireg in two indications associated ...
GlobalData on MSN12h
EMA CHMP recommends Lilly’s Crohn’s therapy for EU approvalCommittee for Medicinal Products for Human Use (CHMP) has recommended Eli Lilly’s Omvoh (mirikizumab) for approval in the ...
GSK (GSK) announced the Committee for Medicinal Products for Human Use, CHMP, of the European Medicines Agency, EMA, has recommended expanding ...
EMA’s human medicine committee recommends marketing approval for acoramidis for treatment of transthyretin amyloid cardiomyopathy: Berlin Monday, December 16, 2024, 13:00 Hrs [I ...
Global biotechnology leader CSL has announced that the European Medicines Agency’s (EMA) Committee for Medicinal Products for ...
GSK (GSK) announced that ViiV Healthcare, the global specialist HIV company majority owned by GSK, with Pfizer (PFE) and Shionogi as ...
Biocon Biologics Ltd today announced that the European Medicines Agency's CHMP has issued a positive opinion recommending approval of YESINTEK®.
EMA recommended 17 drugs for marketing authorization in December, including treatments for rare heart conditions, anemia, and liver disease.
Zacks.com on MSN5h
GILD Obtains Positive CHMP Opinion for Liver Disease DrugGILD announced that the Committee for Medicinal Products for Human Use (“CHMP”) of the European Medicines Agency (“EMA”) ...
The drug has received a nod from the European Medicines Agency's Committee for Medicinal Products for Human Use (CHMP).
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback